Brief: Xspray Pharma Q2 Pretax Loss Sek 6.8 Million
24/08/2018 07:11
Aug 24 (Reuters) - XSpray Pharma AB (publ) XSPRAY.ST :
* Q2 PRETAX LOSS SEK 6.8 MILLION VERSUS PROFIT SEK 681,000 YEAR AGO
Source text for Eikon: ID:nWkr941GdW
Further company coverage: XSPRAY.ST
(Gdynia Newsroom)
((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Xspray Pharma publ AB
See all newsBrief: Xspray Pharma Gets CRL From FDA
Sweden's Xspray Q1 loss narrows, upbeat on Dasynoc prospects
Brief: Xspray Pharma Q1 Pretax Loss SEK 35.4 Mln
Brief: Xspray Pharma To Receive About SEK 113 Million From Rights, Over-Allotment Issues
Brief: FDA Accepts Trade Name Nilopki For Xspray's Drug Candidate XS003